Show simple item record

dc.contributor.authorMulroney, K.
dc.contributor.authorHall, J.
dc.contributor.authorMcGuire, A.
dc.contributor.authorInglis, T.
dc.contributor.authorChakera, Aron
dc.date.accessioned2018-12-13T09:13:02Z
dc.date.available2018-12-13T09:13:02Z
dc.date.created2018-12-12T02:47:04Z
dc.date.issued2018
dc.identifier.citationMulroney, K. and Hall, J. and McGuire, A. and Inglis, T. and Chakera, A. 2018. Case study: Applying rapid flow cytometry analysis to CAPD effluent. Peritoneal Dialysis International. 38 (5): pp. 376-379.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/72333
dc.identifier.doi10.3747/pdi.2017.00231
dc.description.abstract

© 2018, Multimed Inc.. All rights reserved. Peritoneal dialysis (PD) peritonitis cases require rapid clinical interventions to ensure the best possible patient outcomes. Culture-dependent microbiology tools are slow and cannot provide clinicians with evidence to guide antimicrobial prescription practices in an appropriate time frame. Genotypic methods have met with limited success for analyzing continuous ambulatory PD effluent, with most centers still relying on culture-dependent microbiology. We present a case study in which we apply flow cytometry techniques to antibiotic-compromised effluent. We demonstrate, with supporting evidence, direct enumeration of bacterial and human immune cells, with results reported within 2 hours of receiving the clinical specimen.

dc.titleCase study: Applying rapid flow cytometry analysis to CAPD effluent
dc.typeJournal Article
dcterms.source.volume38
dcterms.source.number5
dcterms.source.startPage376
dcterms.source.endPage379
dcterms.source.issn0896-8608
dcterms.source.titlePeritoneal Dialysis International
curtin.departmentCurtin Medical School
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record